|
RCKT | Rocket Pharmaceuticals, Inc. |
|
|
RCKT | Rocket Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.49 |
| Leverage | 12.22% |
| Market Cap | $ 947.6m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -257.4m |
| Margin | 0.00% |
Rocket Pharmaceuticals, Inc., is a cross-platform biotechnology company focused on developing gene therapies for rare and devastating pediatric diseases. The company is headquartered in Cranbury, New Jersey.